Adjust assumptions
Adjust the usable peer mix to see how each valuation multiple moves the blended fair value.
Peer-implied fair value
—
Blended value per share under the current mix.
Current price
—
Market price unavailable
Peer gap
N/A
Peer gap unavailable
Weighting mixer
No usable valuation methods are available for this peer set.
Value contribution
6 peers →Assign weight to at least one usable method to see the contribution split.
Equal-weight baseline
The simple average of every usable peer method, before your weighting adjustments.
Baseline equity value
—
Baseline / share
—
Relative valuation prices this company against what the market already pays for its peers. For a cash-flow view that does not inherit peer sentiment, open the intrinsic model.
Spreadsheet data
Audit the saved peer set and the method inputs behind the blended fair value.
The saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market cap | Enterprise value | Revenue | EBITDA |
|---|
| Net income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
ABT ABBOTT LABORATORIES FY ended Jan 31, 2026 | — | — | — | $44.33B | $12.22B | $6.52B | — | — | — |
MRK Merck & Co., Inc. FY ended Jan 31, 2026 | — | — | — | $65.01B | $28.05B | $18.25B | — | — | — |
BSX BOSTON SCIENTIFIC CORP FY ended Jan 30, 2026 | — | — | — | $20.07B | $5.10B | $2.89B | — | — | — |
JNJ JOHNSON & JOHNSON FY ended Feb 06, 2026 | — | — | — | $94.19B | $37.95B | $26.80B | — | — | — |
ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | — | — | — | $8.23B | $1.92B | $705.10M | — | — | — |
TFX TELEFLEX INC FY ended Feb 25, 2026 | — | — | — | $1.99B | -$676.80M | -$905.64M | — | — | — |
ABT
ABBOTT LABORATORIES
—
—
—
$44.33B
$12.22B
—
—
—
Cap —EV —Rev $44.33BEBITDA $12.22BP/E —P/S —EV/EBITDA —
MRK
Merck & Co., Inc.
—
—
—
$65.01B
$28.05B
—
—
—
Cap —EV —Rev $65.01BEBITDA $28.05BP/E —P/S —EV/EBITDA —
BSX
BOSTON SCIENTIFIC CORP
—
—
—
$20.07B
$5.10B
—
—
—
Cap —EV —Rev $20.07BEBITDA $5.10BP/E —P/S —EV/EBITDA —
JNJ
JOHNSON & JOHNSON
—
—
—
$94.19B
$37.95B
—
—
—
Cap —EV —Rev $94.19BEBITDA $37.95BP/E —P/S —EV/EBITDA —
ZBH
ZIMMER BIOMET HOLDINGS, INC.
—
—
—
$8.23B
$1.92B
—
—
—
Cap —EV —Rev $8.23BEBITDA $1.92BP/E —P/S —EV/EBITDA —
TFX
TELEFLEX INC
—
—
—
$1.99B
-$676.80M
—
—
—
Cap —EV —Rev $1.99BEBITDA -$676.80MP/E —P/S —EV/EBITDA —
Which peer averages feed the weighted fair value, and which methods are excluded.
| Method | Type | Avg. multiple | Coverage | Implied equity value | Fair value / share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | — | 0/6 | — | — | No saved peers have usable coverage for this method. |
Price / Sales PSExcluded | Equity Multiple | — | 0/6 | — | — | No saved peers have usable coverage for this method. |
Price / Earnings PEExcluded | Equity Multiple | — | 0/6 | — | — | No saved peers have usable coverage for this method. |
EV / EBITDA
EV · Enterprise Multiple
Avg. multiple
—
Coverage
0/6
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Sales
PS · Equity Multiple
Avg. multiple
—
Coverage
0/6
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Earnings
PE · Equity Multiple
Avg. multiple
—
Coverage
0/6
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
